Clinical Trial Update: Pulmonary REsistance Modification Under Treatment With Sacubitril/valsartaN in paTients With Heart Failure With Reduced Ejection Fraction [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update investigating sacubitril/valsartan in patients with heart failure with reduced ejection fraction.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Reduced Ejection Fraction

Drugs mentioned

• Sacubitril/Valsartan (sacubitril/valsartan)

Snippet

Sponsor: Clinical Hospital Heliodor Swiecicki of the Medical University of Karol Marcinkowski in Poznań | Conditions: Heart Failure | Phase 4 | Status: UNKNOWN